Augustine Lawlor

Augustine Lawlor (board member) discloses dealings in 5 companies, chiefly Human Genome Sciences Inc, Cardiovascular Systems Inc and Globeimmune Inc. In total, 84 filings cover trades dated from 3 July 2006 to 28 March 2025.

On the open market, the record shows 2 purchases worth €6.4M and 18 sales worth €8.1M. Netting one side against the other leaves €1.7M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 52 share grants and 2 option exercises.

The latest filing, published on 1 April 2025, reports a share grant of €2,285 in Cypherpunk Technologies Inc. The most recent open-market purchase was published on 5 February 2019, 2,818 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.